Metabolomics: Technologies and Global Markets

NEXT STORY
CytoDyn Reminds Stockholders to Register 24 hours before November 24th Annual Meeting
PREV STORY
Bright Peak Therapeutics Licenses Rights to Livzon’s Anti-PD-1 Antibody LZM009 to Develop Novel PD-1 Targeted Immunocytokines
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cue Biopharma Adds Frank Morich, M.D., Ph.D. to Board of Directors

CAMBRIDGE, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc., (NASDAQ:CUE) a next-generation ...

author_avatar
NASDAQ Market News

Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Announces Date of its Annual Meeting of Stockholders

CAMBRIDGE, Mass., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology ...

author_avatar
NASDAQ Market News

American Health Council Honors Julio C. Soto, MD as “Best in Medicine”

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- The American Health Council honors Julio ...

author_avatar
NASDAQ Market News